Literature DB >> 1200033

Renal function in gout. IV. An analysis of 524 gouty subjects including long-term follow-up studies.

L Berger, T F Yü.   

Abstract

Renal function studies were performed in 524 gouty subjects, including follow-up studies at intervals up to 12 years in 112 of them. In 49 subjects, the glomerular filtration rate was less than 70 ml/min and Curate:glomerular filtration rate ratio tended to rise as the glomerular filtration rate decreased, reflecting a relatively stable urate excretion over varying filtered urate loads. The increment in Tsurate:glomerular filtration rate was small with spontaneous Purate between 7 and 9 mg/100 ml. It was modest with Purate up to 10 mg/100 ml. The increment in Tsurate:glomerular filtration rate became much higher beyond Purate of 10 mg/100 ml. Urinary urate levels above 800 mug/min, designated as excess urate excretion, occurred more commonly in subjects with Purate above 9 mg/100 ml, and with better preserved renal function. Tophi were more frequently observed in subjects with low glomerular filtration rate and proteinuria; but incidence of urolithiasis seemed to be less affected by a decrease in the glomerular filtration rate. Hyperuricemia alone had no deleterious effect on renal function as evidenced by follow-up studies over periods up to 12 years. Deterioration of renal function was largely associated with aging, renal vascular disease, renal calculi with pyelonephritis or independently occurring nephropathy. In only very few instances was diminished renal function ascribable to gout alone.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1200033     DOI: 10.1016/0002-9343(75)90222-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  30 in total

1.  Heberden Society. Annual general meeting and oration. Papers.

Authors: 
Journal:  Ann Rheum Dis       Date:  1979-04       Impact factor: 19.103

2.  Pro-inflammatory and oxidative effects of noncrystalline uric acid in human mesangial cells: contribution to hyperuricemic glomerular damage.

Authors:  M S Convento; E Pessoa; M A Dalboni; F T Borges; N Schor
Journal:  Urol Res       Date:  2010-06-04

3.  Heberden Society. Annual General Meeting and Oration.

Authors: 
Journal:  Ann Rheum Dis       Date:  1980-04       Impact factor: 19.103

4.  Proceedings of a symposium on crystal-related arthropathies. 22 October and 23 October, 1982, Bristol Polytechnic, Bristol.

Authors: 
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

5.  Uric acid, gout and the kidney.

Authors:  J S Cameron; H A Simmonds
Journal:  J Clin Pathol       Date:  1981-11       Impact factor: 3.411

6.  Familial gout and renal failure.

Authors:  D J Warren; H A Simmonds; T Gibson; R B Naik
Journal:  Arch Dis Child       Date:  1981-09       Impact factor: 3.791

7.  The risks of asymptomatic hyperuricaemia and the use of uricosuric diuretics.

Authors:  M W Johnson; W E Mitch
Journal:  Drugs       Date:  1981-03       Impact factor: 9.546

Review 8.  Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?

Authors:  Zohreh Soltani; Kashaf Rasheed; Daniel R Kapusta; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

9.  Autosomal dominant transmission of gouty arthritis with renal disease in a large Japanese family.

Authors:  N Yokota; H Yamanaka; Y Yamamoto; S Fujimoto; T Eto; K Tanaka
Journal:  Ann Rheum Dis       Date:  1991-02       Impact factor: 19.103

Review 10.  Gout, uric acid and purine metabolism in paediatric nephrology.

Authors:  J S Cameron; F Moro; H A Simmonds
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.